BDBM667161 N-{5-[6-(5-chloro-2-fluorophenyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-8-yl]pyridin-3-yl}-3-(4-methyl-2-oxopiperazin-1-yl)propanamide::US20240116948, Example 47

SMILES CN1CCN(CCC(=O)Nc2cncc(c2)-c2cc(nc3NCCOc23)-c2cc(Cl)ccc2F)C(=O)C1

InChI Key InChIKey=PSVVPDXOQRPSNY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667161   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667161(US20240116948, Example 47 | N-{5-[6-(5-chloro-2-fl...)
Affinity DataIC50: 7.5nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
US Patent